Comparison of the efficacy between once-monthly oral ibandronate and risedronate among Korean women with osteoporosis: a nationwide population-based study
Sign Up to like & getrecommendations! Published in 2018 at "Osteoporosis International"
DOI: 10.1007/s00198-018-4778-0
Abstract: SummaryUsing a nationwide database from the Korean National Health Insurance Service, this study showed that once-monthly oral ibandronate (150 mg) had better anti-fracture efficacy than once-monthly oral risedronate (150 mg), as seen on assessing overall and non-vertebral… read more here.
Keywords: among korean; ibandronate; efficacy monthly; monthly oral ... See more keywords
Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST study
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Bone and Mineral Metabolism"
DOI: 10.1007/s00774-017-0839-2
Abstract: The non-inferiority of oral ibandronate 100 mg to intravenous (i.v.) ibandronate 1 mg in increasing lumbar spine (LS) bone mineral density (BMD) after 12 months of treatment was demonstrated in the randomized, phase III MOVEST study. We conducted… read more here.
Keywords: ibandronate; oral ibandronate; ibandronate patients; study ... See more keywords
A rapid and sustained improvement of calcification propensity score (serum T50) after successful kidney transplantation: Reanalysis of a randomized controlled trial of ibandronate
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Transplantation"
DOI: 10.1111/ctr.13131
Abstract: A serum test called T50 assesses the overall propensity for calcification of the blood and is associated with cardiovascular outcomes. We aimed to examine T50 over time in kidney transplant recipients and also address any… read more here.
Keywords: ibandronate; year; serum; t50 ... See more keywords
Does Local Ibandronate and/or Pamidronate Delivery Enhance Osseointegration? A Systematic Review
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Prosthodontics"
DOI: 10.1111/jopr.12571
Abstract: PURPOSE To our knowledge from indexed literature, the present study is the first one to systematically review the influence of local delivery of pamidronate (PAM) and/or ibandronate (IBA) on osseointegration enhancement. The aim of the… read more here.
Keywords: ibandronate; iba pam; delivery; systematic review ... See more keywords
Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor–Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.21.00311
Abstract: PURPOSE For postmenopausal patients with breast cancer, previous subgroup analyses have shown a modest benefit from adjuvant bisphosphonate treatment. However, the efficacy of oral nitrogen-containing bisphosphonates such as ibandronate is unclear in this setting. TEAM-IIB… read more here.
Keywords: arm; ibandronate; breast cancer; postmenopausal women ... See more keywords